lexcorp:
The issue of enforcement of patents and the scope of limited licences for limited use is across the board in all biotechs.
It's great if you already understand this and not bothered that you could be oversimplifying with Uh, it's another code, it must be irrelevant!?
No. The scope of licences is very important to understand, as are enforcement processes which protect the IP.
Pretend otherwise by all means. I have explained how it is relevant to AHZ.
high buy, page-132
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.33 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |